Summary
Vertical Longevity Pharmaceuticals, Inc. is a $500,000 offering listed on Netcapital.
The securities are offered under Regulation CF.
Terms shown here are drawn from SEC filings and were captured by AltStreet on 2026-08-13. Figures are as disclosed at the time of the offering and are not updated for subsequent performance.
Disclosed Terms
- Offering amount
- $500,000
- Structure
- Direct Asset
- Status
- Funding closed
- Exemption
- Regulation CF
- Launched
- 2025-10-10
- Closed
- 2026-01-16
Terms as disclosed at the time of the offering. AltStreet does not update these figures for subsequent performance, and a disclosed rate is not a realized return.
Filing Record
The issuer behind Vertical Longevity Pharmaceuticals, Inc. files under Regulation Crowdfunding (Form C). Its offering chain runs from C on Oct 10, 2025 to C-TR on Apr 27, 2026, 3 filings in all. AltStreet's status rule reads the chain as reporting terminated (Form C-TR filed: reporting terminated).
- 2026-09-28Form D filedD$110,000
- 2026-04-27Reporting terminatedC-TR
- 2026-03-30Annual report filedC-AR$0
- 2025-10-10Form C filedC$500,000
From SEC EDGAR, as filed. Issuer filing history.
Evidence on file
19 supporting passages on file for this offering from 1 source document, 1 discrepancy flagged. Each passage carries its page reference and, where one exists, the verbatim quote; the score fields above cite them. Read the passages in the terminal.
- Passages
- 19
- Source documents
- 1
- Analyst verified
- 0
- Discrepancies
- 1
Terminal Analysis
Terminal analysis for this offering
Terminal access unlocks 19 cited passages from the offering documents with page references.
Access full researchQuestions About This Offering
What is Vertical Longevity Pharmaceuticals, Inc.?
Vertical Longevity Pharmaceuticals, Inc. is a $500,000 offering listed on Netcapital. The securities are offered under Regulation CF. Terms shown here are drawn from SEC filings and were captured by AltStreet on 2026-08-13. Figures are as disclosed at the time of the offering and are not updated for subsequent performance.
Who is the issuer of Vertical Longevity Pharmaceuticals, Inc.?
The offering relies on Regulation CF, which allows any investor to participate within annual limits.
When did Vertical Longevity Pharmaceuticals, Inc. launch and close?
The offering launched on 2025-10-10. It closed on 2026-01-16. AltStreet records its status as funding closed.
Is Vertical Longevity Pharmaceuticals, Inc. still open to investors?
AltStreet's record shows the offering as funding closed. AltStreet tracks this offering from SEC filings, last captured 2026-08-13. Offering status changes without a corresponding filing in many cases, so current availability should be confirmed directly with Netcapital before acting.
Related Offerings on Netcapital
HeadFarm, LLC
Real Estate
Winglore Spirits Incorporated
Wine Spirits
Future Proof Property Intelligence, PBC
Real Estate
Resurgent, Inc.
Real Estate
21st Street Properties, LLC
Real Estate
LiquidVineyards LLC
Wine Spirits
EnergyX Regulation CF, offering 020-27164
Energy Transition
EnergyX Regulation CF, offering 020-27962
Energy Transition
Ocean Renewable Power Company, Inc.
Energy Transition
PropertyClub, Inc.
Real Estate
GT Spirits Inc
Wine Spirits
Absinthia's Bottled Spirits, LLC
Wine Spirits
Absinthia's Bottled Spirits, LLC
Wine Spirits
Longevity Biotech offerings on other platforms
All Netcapital offerings →All longevity biotech offerings →